Saturday, May 08, 2021
View Larger +
Kelsey M. Mullen, 36, died Saturday, May 1, 2021, surrounded by her loving family at Miriam Hospital in Providence. She and her husband of five years Ryen D. Mullen shared over ten years together full of love and adventure.
Born in Providence, she was the daughter of Walter and Joan (Pizzo) Hobbs of Lincoln. Kelsey had lived in Smithfield for four years.
Kelsey was a Child Life Specialist at Hasbro Children’s Hospital for 14 years. She was a graduate of Wheelock College in Boston. Kelsey loved caring for the kids in the Tomorrow Fund Clinic and was always empowered to see the resiliency of the kids and their families during what is often the hardest parts of their lives. As the Tomorrow Fund Clinic’s Child Life Specialist, Kelsey was also the program director for the annual, week-long, day camp at Hasbro called Camp Dotty for children with cancer and their siblings. This week-long camp was always the most taxing but rewarding part of h
5/4/2021
Veliz, Konte named valedictorian, salutatorian at Tolman High
Melany Veliz, left, valedictorian of the Class of 2021 at Tolman High, and Hanatha Konte, was named salutatorian.
PAWTUCKET – The valedictorian and salutatorian of Tolman High School’s Class of 2021 both say they’ll remember their time at the high school fondly, particularly the diversity of the student population here.
Melany Veliz, with a GPA of 4.242, has been named valedictorian of the Class of 2021 at Tolman High, while Hanatha Konte, with a GPA of 4.173, is salutatorian.
Veliz, daughter of Jose and Alma Veliz, said she was surprised when she first learned she was named valedictorian, saying that she had ranked third in her class for a while but decided this past year to work even harder.
CORONAVIRUS
Rare blood clots up to 10 times more likely from COVID-19 infection than from Johnson & Johnson vaccine, report says
The chief of neurology at Lifespan Corporation says blood clots arenât the only long-term effects she has seen in patients who have had COVID-19.
By Alexa Gagosz Globe Staff,Updated May 3, 2021, 6:34 p.m.
Email to a Friend
The COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, is at Rhode Island Hospital.Jonathan Wiggs/Globe Staff
PROVIDENCE â The same rare blood clot condition connected to the Johnson & Johnson COVID-19 vaccine is more of a risk following a COVID-19 infection, according to a newly released report.
Daniel J. McKee, D- Rhode Island, issued the following news release:. Governor Dan McKee, joined by House Speaker K. Joseph Shekarchi, Senate President Dominick J. Ruggerio, Senate Majority Whip Maryellen Goodwin and House Deputy Majority Whip Mia A. Ackerman, today signed into law the Maryellen Goodwin Colorectal Cancer Screening Act which provides full insurance.
Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine
Last Friday, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S. The temporary pause was due to reports of a serious condition called cerebral venous sinus thrombosis (CVST), which refers to blood clots in the brain s veins - not in the arteries, as is the case for most strokes - in combination with thrombocytopenia (low blood platelet count).
CVST and thrombocytopenia together is called thrombosis-thrombocytopenia syndrome (TTS). When TTS is linked to receiving a COVID-19 vaccine, it is called vaccine-induced immune thrombotic thrombocytopenia (VITT). CVST has also been associated with cases of TTS in adults who received the AstraZeneca COVID-19 vaccine available in Europe, according to the European Medicines Agency, the agency responsible f